Capricor Therapeutics Stock Predictions

Top investors are buying this "unlisted" stock

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Sell

CAPR
Capricor Therapeutics

Last Price:

$7.11

Seasonality Move:

5.63%

7 Day Trial

ALL ACCESS PASS

$ 7

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.

Capricor Therapeutics Stock Forecast

Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 12.5% based on the past 19 years of stock performance.
Capricor Therapeutics has fallen lower in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%
Is Capricor Therapeutics Stock Undervalued?

The current Capricor Therapeutics [CAPR] share price is $6.34. The Score for CAPR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
CAPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Capricor Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Capricor Therapeutics has on average historically fallen by 12.5% based on the past 19 years of stock performance.

Capricor Therapeutics Stock Rating

Sell

Capricor Therapeutics (CAPR) is a Sell

Is Capricor Therapeutics overpriced?

Capricor Therapeutics has fallen lower in 10 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 52.63%

Capricor Therapeutics Stock Price History

Is CAPR stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CAPR is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

capricor.com

52-Week Data

52-Week High:

23.40

52-Week Low:

3.52

Prediction Charts

Market Cap:

289.6M

Price in USD:

6.34

Volume:

3.6M

Beta:

1.20

Technical Analysis

SMA50:

11.47

SMA100:

12.86

SMA200:

12.27

52-Wk Change:

16.97%

Stock Predictions

Is Capricor Therapeutics stock public?

Yes, Capricor Therapeutics is a publicly traded company.
What is the Capricor Therapeutics stock quote today?

The Capricor Therapeutics stock price is 6.34 USD today.
How to buy Capricor Therapeutics stock online?

You can buy Capricor Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Apr-22	12.12	13.89	14.08	12.02
Apr-23	14.20	13.15	14.45	12.89
Apr-24	13.21	13.28	13.99	12.95
Apr-25	13.12	13.03	13.35	12.59
Apr-28	13.10	12.83	13.42	12.63
Apr-29	12.83	12.56	12.98	12.36
Apr-30	12.17	12.70	12.87	12.16
May-1	12.65	12.74	13.07	12.30
May-2	12.95	11.86	13.22	11.69
May-5	11.22	10.30	11.33	9.99
May-6	10.30	7.30	10.35	6.97
May-7	7.58	6.89	7.59	6.79
May-8	7.01	6.97	7.51	6.57
May-9	6.99	6.34	7.10	6.27

Capricor Therapeutics Earnings

Capricor Therapeutics Earnings Report: Per Share Capricor Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Capricor Therapeutics Forecast Revenue Growth

Capricor Therapeutics Stock Analysis: Historical quarterly revenues per share for Capricor Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.65 per share, an increase this year of $0.82 per share, and an increase next year of $0.18 per share.

* Capricor Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.